Arcticzymes Technologies ASA (AZT.OL) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Norway · ISIN NO0010014632
Arcticzymes Technologies ASA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 104.35 m NOK | 112.62 m NOK |
| Gross profit | 98.37 m NOK | 107.94 m NOK |
| Operating income | -1.44 m NOK | 2.81 m NOK |
| EBIT | -1.44 m NOK | 12.27 m NOK |
| Net income | 8.47 m NOK | 9.88 m NOK |
| Diluted EPS – continuing operations | 0.17 NOK | 0.19 NOK |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Arcticzymes Technologies ASA
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools market, and biomanufacturing markets. It operates in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
More stocks
- Northcliff Resources Ltd (NCF.TO)
- Exel Composites Oyj (EXEL.HE)
- Legacy Ventures International Inc (LGYV)
- Organogenesis Holdings Inc. (ORGO)
- PT Intra GolfLink Resorts Tbk (GOLF.JK)
- Ubiqconn Technology, Inc. (6928.TW)
- Daewon Pharmaceutical Co. Ltd. (003220.KS)
- Audinate Group Ltd (AD8.AX)
- Food Moments PCL (FM.BK)
- HB Technology CO.LTD (078150.KQ)
- RedcapTour Co. Ltd (038390.KQ)
- Youngchang Chemical Co. Ltd. (112290.KQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.